Research News

MRC Public Health Intervention Development Scheme (PHIND)

Wednesday, 06 November 2013 09:53

The Public Health Intervention Development scheme (PHIND) is a new MRC funding scheme designed specifically to provide support for early phase development of public health interventions. This rapid response funding scheme is aimed at improving the initial evidence on which the development and evaluation of public health interventions are based. Studies should address an important UK or global public health issue and offer an innovative approach to intervention development or applying an existing intervention in a new setting.

The scheme's remit ranges from primary research developing and designing the intervention to feasibility studies, encompassing:

  • developing theory
  • modelling process and outcomes
  • assessing feasibility

Systematic reviews, meta analyses and pilot studies are outside the remit of the PHIND scheme. Applicants can apply for up to £150K for a maximum of 18 months and the scheme will operate three times a year. For further information, please see the MRC website.

Antimicrobial Resistance Themed Call

Wednesday, 06 November 2013 09:31

The PHR Programme is now accepting applications in response to the NIHR Antimicrobial Resistance (AMR) Themed Call. Please check the AMR Themed Call website for further information. The deadline for this call is 1pm, 19 November 2013.

We are pleased to be able to share the PHR Programme AMR themed call webinar that took place on 2 October. This session addresses some key questions and tips about remit, and how to apply to this NIHR PHR funding opportunity. Watch the webinar

HCV clinical trial and tissue biobank

Wednesday, 16 October 2013 11:59

Professor Will Irving ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ) is chief investigator for an observational study (UKCRN 11582) of 10,000 patients with laboratory evidence of HCV infection, either past or current. Information about the study is included as 'Study of the Month' in the October NIHR Specialty Group newsletter. The aim is to develop a biobank, analyse the contribution of a range of host and viral factors to disease outcome, and determine the clinical utility of routine IL-28B genotyping in the management of HCV-infected patients in the UK. For further information please contact Professor Irving.

 

National Institute for Health Research announces hospital trusts to host branches of the Clinical Research Network

Wednesday, 02 October 2013 11:15

The Department of Health, through the National Institute for Health Research (NIHR), has announced the15 hospital Trusts that will host the local branches of the NIHR Clinical Research Network from April 2014. The 15 Trusts will take responsibility for performing the remit of the NIHR Clinical Research Network at local level and collectively will distribute £280 million of NIHR funding per year, to support the delivery of clinical research studies in their area.

Page 5 of 10